High Court Told 'Public Use' Rule Nixes Pronova Patent
Two generic-drug makers have asked the high court to decline to review a Federal Circuit decision nixing a drug patent, saying the appeals court correctly found that Pronova BioPharma Norge AS...To view the full article, register now.
Already a subscriber? Click here to view full article